Baillie Gifford & Co’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.11M | Sell |
300,137
-2,597
| -0.9% | -$44.2K | ﹤0.01% | 225 |
|
|
2025
Q1 | $5.91M | Sell |
302,734
-5,502
| -2% | -$107K | 0.01% | 226 |
|
|
2024
Q4 | $7.64M | Sell |
308,236
-49,462
| -14% | -$1.23M | 0.01% | 216 |
|
|
2024
Q3 | $8.76M | Sell |
357,698
-265,942
| -43% | -$6.52M | 0.01% | 217 |
|
|
2024
Q2 | $14.6M | Sell |
623,640
-128,754
| -17% | -$3.02M | 0.01% | 194 |
|
|
2024
Q1 | $24.9M | Sell |
752,394
-11,729
| -2% | -$388K | 0.02% | 181 |
|
|
2023
Q4 | $20.8M | Sell |
764,123
-111,624
| -13% | -$3.04M | 0.02% | 189 |
|
|
2023
Q3 | $21.1M | Buy |
875,747
+352,014
| +67% | +$8.47M | 0.02% | 182 |
|
|
2023
Q2 | $16.7M | Buy |
523,733
+70,972
| +16% | +$2.27M | 0.01% | 189 |
|
|
2023
Q1 | $13.9M | Sell |
452,761
-2,067
| -0.5% | -$63.3K | 0.01% | 203 |
|
|
2022
Q4 | $17.8M | Buy |
454,828
+69,610
| +18% | +$2.72M | 0.02% | 191 |
|
|
2022
Q3 | $18.4M | Buy |
385,218
+374,545
| +3,509% | +$17.8M | 0.02% | 191 |
|
|
2022
Q2 | $413K | Hold |
10,673
| – | – | ﹤0.01% | 287 |
|
|
2022
Q1 | $612K | Hold |
10,673
| – | – | ﹤0.01% | 283 |
|
|
2021
Q4 | $851K | Sell |
10,673
-27
| -0.3% | -$2.15K | ﹤0.01% | 282 |
|
|
2021
Q3 | $931K | Buy |
10,700
+10,213
| +2,097% | +$889K | ﹤0.01% | 275 |
|
|
2021
Q2 | $63K | Sell |
487
-32
| -6% | -$4.14K | ﹤0.01% | 283 |
|
|
2021
Q1 | $42K | Buy |
519
+24
| +5% | +$1.94K | ﹤0.01% | 287 |
|
|
2020
Q4 | $40K | Buy |
+495
| New | +$40K | ﹤0.01% | 279 |
|